Studies have shown that the decrease in LYVE-1 expression (structural damage) and the decrease in tracer drainage efficiency (functional defect) in AD mice occur synchronously at 6 months of age, and Aβ deposition increases significantly thereafter. Here, LYVE1 is linked to Alzheimer disease.